Riverine Ventures

riverine.ventures

VCMatch tracks Riverine Ventures as an investor focused on Biotech, Pharma, and Medtech companies. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

Biotech, Pharma, Medtech

Geography

Not specified

Investment Thesis

Riverine positions itself as a science‑first, clinician‑informed VC that combines capital with operational guidance and commercial networks to advance life science and healthcare innovations. The firm emphasizes partnering with management teams to build “more precise, personalized and cost-effective medical products and services,” with a particular belief that “the future is precision medicine.” Riverine frames its work around being “grounded in science, innovation and perseverance” and centers consumers and patients in its evaluation of opportunities.

Is Riverine Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Riverine Ventures is most relevant for founders raising venture-backed rounds in Biotech, Pharma, Medtech, and Digital Health.

Focus statement

A life‑science and healthcare‑dedicated VC that provides "capital, networks and guidance" to entrepreneurs building solutions across biopharma, medtech and digital health, with a focus on precision medicine and patient‑centric, personalized, cost‑effective clinical products and services.

Value Add

Founder/Managing Partner is a clinician and experienced operator (Garrett Vygantas, MD, MBA) who "provides strategic direction and valuable clinical and commercial networks," giving the firm deep clinical credibility and operational experience.
Explicit combination of capital + networks + guidance (positioned as a "next‑generation VC").
Track record across multiple exits and investments spanning biopharma, medtech and digital health (demonstrated portfolio and prior successful investments/acquisitions).
Patient/consumer‑centric investment lens — decisions framed by clinical realities and clinician experience.